OBJECTIVES: This study aimed to illustrate the indications for, and types and outcomes of surgical portosystemic shunt (PSS) and/or Rex bypass in a single centre. METHODS: Data were collected from children with a PSS and/or Rex bypass between 1992 and 2006 at Mount Sinai Medical Center, New York. RESULTS: Median age at surgery was 10.7 years (range 0.3-22.0 years). Indications included: (i) refractory gastrointestinal bleeding in portal hypertension associated with (a) compensated cirrhosis (n= 12), (b) portal vein thrombosis (n= 10), (c) hepatoportal sclerosis (n= 3); (ii) refractory ascites secondary to Budd-Chiari syndrome (n= 3), and (iii) familial hypercholesterolaemia (n= 4). There were 20 distal splenorenal, four portacaval, three Rex bypass, two mesocaval, two mesoatrial and one proximal splenorenal shunts. At the last follow-up (median 2.9 years, range 0.1-14.1 years), one shunt (Rex bypass) was thrombosed. Two patients had died and two had required a liver transplant. These had a patent shunt at last imaging prior to death or transplant. CONCLUSIONS: Portosystemic shunts and Rex bypass have been used to manage portal hypertension with excellent outcomes. In selected children with compensated liver disease, PSS may act as a bridge to liver transplantation or represent an attractive alternative.
OBJECTIVES: This study aimed to illustrate the indications for, and types and outcomes of surgical portosystemic shunt (PSS) and/or Rex bypass in a single centre. METHODS: Data were collected from children with a PSS and/or Rex bypass between 1992 and 2006 at Mount Sinai Medical Center, New York. RESULTS: Median age at surgery was 10.7 years (range 0.3-22.0 years). Indications included: (i) refractory gastrointestinal bleeding in portal hypertension associated with (a) compensated cirrhosis (n= 12), (b) portal vein thrombosis (n= 10), (c) hepatoportal sclerosis (n= 3); (ii) refractory ascites secondary to Budd-Chiari syndrome (n= 3), and (iii) familial hypercholesterolaemia (n= 4). There were 20 distal splenorenal, four portacaval, three Rex bypass, two mesocaval, two mesoatrial and one proximal splenorenal shunts. At the last follow-up (median 2.9 years, range 0.1-14.1 years), one shunt (Rex bypass) was thrombosed. Two patients had died and two had required a liver transplant. These had a patent shunt at last imaging prior to death or transplant. CONCLUSIONS: Portosystemic shunts and Rex bypass have been used to manage portal hypertension with excellent outcomes. In selected children with compensated liver disease, PSS may act as a bridge to liver transplantation or represent an attractive alternative.
Authors: Benjamin Shneider; Sukru Emre; Roberto Groszmann; John Karani; Patrick McKiernan; Shiv Sarin; Harohalli Shashidhar; Robert Squires; Riccardo Superina; Jean de Ville de Goyet; Roberto de Franchis Journal: Pediatr Transplant Date: 2006-12
Authors: M López-Santamaria; L Migliazza; M Gamez; J Murcia; M Diaz-Gonzalez; C Camarena; L Hierro; A De la Vega; E Frauca; M Diaz; P Jara; J Tovar Journal: J Pediatr Surg Date: 2000-04 Impact factor: 2.545
Authors: E Cabré; E Navarro; M de Ramon; J Klaassen; R Planas; M D Mingorance; M C Pastor; M Lachica; J Boix; M A Gassull Journal: JPEN J Parenter Enteral Nutr Date: 1996 May-Jun Impact factor: 4.016
Authors: J de Ville de Goyet; D Alberti; P Clapuyt; D Falchetti; V Rigamonti; N M Bax; J B Otte; E M Sokal Journal: J Pediatr Surg Date: 1998-04 Impact factor: 2.545
Authors: J Michael Henderson; Thomas D Boyer; Michael H Kutner; John R Galloway; Layton F Rikkers; Lennox J Jeffers; Kareem Abu-Elmagd; Jason Connor Journal: Gastroenterology Date: 2006-05 Impact factor: 22.682
Authors: Ernesto P Molmenti; Dorry L Segev; Aravind Arepally; Jenny Hong; Paul J Thuluvath; Rudra Rai; Andrew S Klein Journal: Ann Surg Date: 2005-06 Impact factor: 12.969
Authors: Cara L Mack; Frank A Zelko; Joan Lokar; Riccardo Superina; Estella M Alonso; Andres T Blei; Peter F Whitington Journal: Pediatrics Date: 2006-02-15 Impact factor: 7.124